Pharmacological actions of nobiletin in the modulation of platelet function

British Journal of Pharmacology

Volumn 172, Issue 16, 2015, Pages 4133-4145

  Vaiyapuri, Sakthivel ^a   Roweth, Harvey ^a   Ali, Marfoua S ^a   Unsworth, Amanda J ^a   Stainer, Alexander R ^a   Flora, Gagan D ^a   Crescente, Marilena ^a   Jones, Chris I ^a   Moraes, Leonardo A ^a,b   Gibbins, Jonathan M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC GMP; CYCLIC NUCLEOTIDE; FIBRINOGEN; GLYCOPROTEIN; GLYCOPROTEIN VI; INTEGRIN; INTEGRIN ALPHA2BETA3; NOBILETIN; PHOSPHOLIPASE C GAMMA2; PHOSPHOPROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; FIBRINOGEN RECEPTOR; FLAVONE DERIVATIVE;

AGGREGOMETRY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BLEEDING TIME; BLOOD CLOTTING; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANIMAL; BLOOD CLOTTING TEST; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CALCIUM; CELLS, CULTURED; CYCLIC GMP; FIBRINOGEN; FLAVONES; HUMANS; MICE, INBRED C57BL; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; THROMBOSIS;

EID: 84937515973     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13191     Document Type: Article

References (44)

1. Akao Y, Itoh T, Ohguchi K, Iinuma M, Nozawa Y, (2008). Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg Med Chem 16: 2803-2810.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors. Br J Pharmacol 170: 1676-1705.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
4. Barrett NE, Holbrook L, Jones S, Kaiser WJ, Moraes LA, Rana R, et al. (2008). Future innovations in anti-platelet therapies. Br J Pharmacol 154: 918-939.
5. Benavente-Garcia O, Castillo J, (2008). Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56: 6185-6205.
6. Benavente-Garcbox drawings light down and left'a OCJ, Marin FR, Ortun A, Del Rbox drawings light down and left'o JA, (1997). Uses and properties of citrus flavonoids. J Agric Food Chem 45: 4505-4515.
7. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, et al. (1994). cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269: 14509-14517.
8. Calderwood DA, (2004). Integrin activation. J Cell Sci 117: 657-666.
9. Chen C, Ono M, Takeshima M, Nakano S, (2014). Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Res 34: 1785-1792.
10. Francis SH, Blount MA, Corbin JD, (2011). Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol Rev 91: 651-690.
11. Freedman JE, Parker C 3rd, Li L, Perlman JA, Frei B, Ivanov V, et al. (2001). Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103: 2792-2798.
12. Geiger J, (2001). Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs 10: 865-890.
13. Gibbins JM, (2004). Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci 117: 3415-3425.
14. Hathaway DR, Adelstein RS, (1979). Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci U S A 76: 1653-1657.
15. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, et al. (2012). Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95: 740-751.
16. Hubbard GP, Stevens JM, Cicmil M, Sage T, Jordan PA, Williams CM, et al. (2003). Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 1: 1079-1088.
17. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM, (2004). Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2: 2138-2145.
18. Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA, (2006). Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr 96: 482-488.
19. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, et al. (2001). The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 134: 1106-1114.
20. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, Group NCRRGW (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
21. Li Z, Ajdic J, Eigenthaler M, Du X, (2003a). A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. Blood 101: 4423-4429.
22. Li Z, Xi X, Gu M, Feil R, Ye RD, Eigenthaler M, et al. (2003b). A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 112: 77-86.
23. Lill G, Voit S, Schror K, Weber AA, (2003). Complex effects of different green tea catechins on human platelets. FEBS Lett 546: 265-270.
24. Mackman N, (2008). Triggers, targets and treatments for thrombosis. Nature 451: 914-918.
25. Manthey JA, Cesar TB, Jackson E, Mertens-Talcott S, (2011). Pharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry. J Agric Food Chem 59: 145-151.
26. Matter WF, Brown RF, Vlahos CJ, (1992). The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186: 624-631.
27. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
28. Michelson AD, (2008). P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol 28: s33-s38.
29. Middleton E Jr, Kandaswami C, Theoharides TC, (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
30. Ok WJ, Cho HJ, Kim HH, Lee DH, Kang HY, Kwon HW, et al. (2012). Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner. J Atheroscler Thromb 19: 337-348.
31. Onselaer MB, Oury C, Hunter RW, Eeckhoudt S, Barile N, Lecut C, et al. (2014). The Ca(2+) /calmodulin-dependent kinase kinase beta-AMP-activated protein kinase-alpha1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets. J Thromb Haemost 12: 973-986.
32. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42: D1098-106.
33. Robbins RC, (1973). Antithrombogenic properties of a hexamethoxylated flavonoid. Reduction of deaths in rats due to intravascular infusion of adenosine diphosphate (ADP). Atherosclerosis 18: 73-82.
34. Robbins RC, (1988). Flavones in citrus exhibit antiadhesive action on platelets. Int J Vitam Nutr Res 58: 418-421.
35. Sempinska E, Kostka B, Krolikowska M, Kalisiak E, (1977). Effect of flavonoids on the platelet adhesiveness in repeatedly bred rats. Pol J Pharmacol Pharm 29: 7-10.
36. Shattil SJ, Brass LF, (1987). Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 262: 992-1000.
37. Shi MD, Liao YC, Shih YW, Tsai LY, (2013). Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Phytomedicine 20: 743-752.
38. Vaiyapuri S, Ali MS, Moraes LA, Sage T, Lewis KR, Jones CI, et al. (2013). Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. Arterioscler Thromb Vasc Biol 33: 2740-2749.
39. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
40. Walle T, (2007). Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin Cancer Biol 17: 354-362.
41. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, et al. (2010). A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br J Pharmacol 159: 1312-1325.
42. Wright B, Spencer JP, Lovegrove JA, Gibbins JM, (2012). Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovasc Res 97: 13-22.
43. Wu YQ, Zhou CH, Tao J, Li SN, (2006). Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms. Life Sci 78: 2689-2696.
44. Yasuda T, Yoshimura Y, Yabuki H, Nakazawa T, Ohsawa K, Mimaki Y, et al. (2003). Urinary metabolites of nobiletin orally administered to rats. Chem Pharm Bull (Tokyo) 51: 1426-1428.